The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with impaired fasting glucose or impaired glucose tolerance at the University of Missouri. The aim of the study is to advance understanding of how growth hormone affects beta-cells and risk factors for developing type 2 diabetes.
body mass index >18.5kg/m2 and <45.9kg/m2
impaired fasting glucose >/= 100mg/dL, </= 126mg/dL or impaired glucose tolerance on 75g oral glucose tolerance test (blood glucose 140 to 199mg/dL at two-hours)
pregnant, planning to become pregnant during the study, or breastfeeding
current diagnosis or history of type 1 or type 2 diabetes
use of medications that can impact the study outcomes (e.g., GLP-1 receptor agonists)
history of bariatric surgery
The study population will consist of lean and obese people ages 18-59 with impaired fasting glucose or impaired glucose tolerance.
Cohort
Prospective
Not listed
Beta-cell function
Insulin secretion rate in relationship to plasma glucose
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
